Overview
- 22 FDA inspections are on record.
- 12 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-04-02.
At a glance
Inspections
22
Form 483s
12
EIRs
1
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 23 Mar 2026 – 2 Apr 2026 | Human Drugs | 483 | View 483 → |
| 16 Sep 2024 – 20 Sep 2024 | Human Drugs | 483 | View 483 → |
| 4 Sep 2024 – 13 Sep 2024 | Human Drugs | 483 | On file |
| 12 Apr 2021 – 21 Apr 2021 | Human Drugs | 483 | View 483 → |
| 21 Mar 2016 – 4 Apr 2016 | Human Drugs | 483 | View 483 → |
| 10 Feb 2014 – 19 Feb 2014 | Human Drugs | 483 | On file |
| 1 Nov 2012 | Not recorded | WL | |
| 15 Apr 2011 | Not recorded | 483 | On file |
| 5 Nov 2010 | Not recorded | 483 | View 483 → |
| 1 Dec 2009 | Not recorded | 483 | View 483 → |
| 14 Nov 2008 | Not recorded | 483 | View 483 → |
| 8 Aug 2008 | Not recorded | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
Investigators
FDA investigators tied to this site in the record.
Michele L Obert3 insp.
Shirley J Berryman3 insp.
Matthew R Sleeter3 insp.
Warren J Lopicka3 insp.
Melissa M Steiger2 insp.
Danial S Hutchison2 insp.
Jonathan R Campos1 insp.
Carmen Y Fisher1 insp.
Robert J Ham1 insp.
Carl A Huffman1 insp.
Torrey M Ward1 insp.
Brett R Havranek1 insp.
Jeannie M Vonderbrink1 insp.
Zachary A Bogorad1 insp.
Susanna E Ford1 insp.
Daniel R Hurt1 insp.
Kellia N Hicks1 insp.
James D Planchon1 insp.
Rebecca Rodriguez1 insp.
Lisa L Gilliam1 insp.
Cody D Rickman1 insp.
Tara L Breckenridge1 insp.
Megan M Kirk1 insp.
Patrick L Wisor1 insp.
Aref M El-Demerdash1 insp.
Gwyn G Dickinson1 insp.
Cynthia M Goudeau1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 10x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 5x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.188(b)(11) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.137(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.165(d) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.166(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.67(b)(3) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.103 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.111 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.115(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(5) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(8) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.198(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.56(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.80(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.80(c)(1)(i) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.81(b)(2)(iv)(a) | Cited across public-safe Form 483 observations | 1x |
| FDCA 582(b)(4) | Cited across public-safe Form 483 observations | 1x |
| FDCA 582(g)(1) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind MPP PHARMA LLC's 12 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat